New stroke drug shows promise in early trial

NCT ID NCT07279493

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental drug called KPCXM18 in people who have had an acute ischemic stroke within the past 12 hours. About 300 participants will receive either a low dose, a high dose, or a placebo by IV twice daily for about 12 days. The main goal is to see if the drug helps reduce disability 90 days after the stroke.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

KPCXM18 injection

What this could lead to

If successful, this could point toward a new treatment to reduce disability after a stroke.

What could go wrong

This is an early Phase 2b trial with only 300 people, so results may not confirm benefit. The drug is still experimental and safety is not fully known.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Affiliated Central Hospital Of Shenyang Medical College

    RECRUITING

    Shenyang, Liaoning, China

  • Beijing Tiantan Hosptial,Capital Medical University

    RECRUITING

    Beijing, Beijing Municipality, China

  • Cangzhou Central Hospital

    RECRUITING

    Cangzhou, Hebei, China

  • Da Qing Long Nan Hospital

    RECRUITING

    Daqing, Heilongjiang, China

  • Daqing Oilfield General Hospital

    RECRUITING

    Daqing, Heilongjiang, China

  • First People's Hospital Of Tancheng

    RECRUITING

    Linyi, Shandong, China

  • Hengshui People's Hospital

    RECRUITING

    Hengshui, Hebei, China

  • Jiaxing Second Hospital

    RECRUITING

    Jiaxing, Zhejiang, China

  • Linfen Central Hospital

    RECRUITING

    Linfen, Shanxi, China

  • Linfen People's Hospital

    RECRUITING

    Linfen, Shanxi, China

  • Linyi People's Hospital

    RECRUITING

    Linyi, Shandong, China

  • Meihakou Central Hospital

    RECRUITING

    Meihekou, Jilin, China

  • Nanshi Hospital Of Nanyang

    RECRUITING

    Nanyang, Henan, China

  • Nanyang Second General Hospital

    RECRUITING

    Nanyang, Henan, China

  • Shenzhen Second People's Hospital

    RECRUITING

    Shenzhen, Guangdong, China

  • Sinopharm Tongmei General Hospital

    RECRUITING

    Datong, Shanxi, China

  • Tengzhou Central People's Hospital

    RECRUITING

    Tengzhou, Shandong, China

  • The First Affiliated Hospital Of Nanyang Medical College

    RECRUITING

    Nanyang, Henan, China

  • The First People's Hospital Of Shenyang

    RECRUITING

    Shenyang, Liaoning, China

  • The People's Hospital Of Anyang City

    RECRUITING

    Anyang, Henan, China

  • The People's Hospital Of Liaoning Province

    RECRUITING

    Shenyang, Liaoning, China

  • Xuzhou Central Hospital

    RECRUITING

    Xuzhou, Jiangsu, China

  • Yan'an University Xianyang Hospital

    RECRUITING

    Xianyang, Shaanxi, China